These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

194 related items for PubMed ID: 16388773

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Combination therapy with HMG CoA reductase inhibitors and gemfibrozil: practical or perilous?
    Duell PB, Illingworth DR.
    Heart Dis Stroke; 1993; 2(3):260-2. PubMed ID: 8137035
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Fenofibric Acid (trilipix).
    Med Lett Drugs Ther; 2009 May 04; 51(1311):33-4. PubMed ID: 19417718
    [No Abstract] [Full Text] [Related]

  • 30. [On behalf and the extent of evidence].
    Ruiz J.
    Rev Med Suisse; 2010 Jun 09; 6(252):1171-2. PubMed ID: 20614750
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Colesevelam hydrochloride in the management of dyslipidemia.
    Armani A, Toth PP.
    Expert Rev Cardiovasc Ther; 2006 May 09; 4(3):283-91. PubMed ID: 16716090
    [Abstract] [Full Text] [Related]

  • 33. The efficacy and safety of ezetimibe for treatment of dyslipidemia after heart transplantation.
    Crespo-Leiro MG, Paniagua MJ, Marzoa R, Grille Z, Naya C, Flores X, Rodriguez JA, Mosquera V, Franco R, Castro-Beiras A.
    Transplant Proc; 2008 Nov 09; 40(9):3060-2. PubMed ID: 19010194
    [Abstract] [Full Text] [Related]

  • 34. Persistent use of against-label statin-fibrate combinations from 2003-2009 despite United States Food and Drug Administration dose restrictions.
    Alford JC, Saseen JJ, Allen RR, Nair KV.
    Pharmacotherapy; 2012 Jul 09; 32(7):623-30. PubMed ID: 22570173
    [Abstract] [Full Text] [Related]

  • 35. Achieving cholesterol goals. Current and future drug therapies.
    Jones PH.
    Postgrad Med; 2003 Aug 09; 114(2 Suppl):14-21. PubMed ID: 19667635
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Cholesterol absorption inhibitors: a closer look.
    Lehmann R, Ramsey LA.
    Adv Nurse Pract; 2003 Nov 09; 11(11):28-31. PubMed ID: 14639879
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.